Digital Health

In a recent study funded and coauthored by the company, the EaseVRx program outperformed a non-interactive headset app across several self-reported pain and pain-interference measures.

Medication delivery is currently available in metro areas of New York City, Chicago, Minneapolis, Boston and Austin.   

The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients. 

Also: MGH and MIT create new tool for organizations to calculate benefits of onsite COVID-19 testing and Scanwell teams up with BD for a home coronavirus test.

Digitally treating osteoarthritis through clinical, evidence-based programs can be more effective at reducing pain and improving physical function than routine self-managed care, according to research from JAMA Network Open.

The University Health Network study is being conducted in collaboration with the tech giant, and will enroll roughly 200 patients for three months of active monitoring with a two-year follow-up.

Also: The Consumer Technology Association releases industry standards focused on health AI trust; new updates in the home COVID-19 testing market.

Community by Current Health is now enrolling participants in a COVID-19 study that uses its FDA-cleared remote monitoring system.   

Also: docdok.health rolling out COVID-19 vaccination study app; IBM Watson Health partners with Humana.

MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.